Mannose-binding lectin (MBL) as prognostic factor in paediatric oncology patients

Clinical and Experimental Immunology

Volumn 165, Issue 1, 2011, Pages 51-59

  Frakking, F N J ^a   Brouwer, N ^b   Dolman, K M ^a,b   van Woensel, J B M ^a   Caron, H N ^a   Kuijpers, T W ^a,b   van de Wetering, M D ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cancer; Children; Immunity; Mannose binding lectin; Prognosis

Indexed keywords

MANNOSE BINDING LECTIN;

ARTICLE; CANCER PATIENT; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; EVENT FREE SURVIVAL; FEBRILE NEUTROPENIA; FEMALE; GENOTYPE; HAPLOTYPE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEFICIENCY; SCHOOL CHILD; SEPTIC SHOCK;

ADULT; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; EMERGENCY MEDICAL SERVICES; GENETIC PREDISPOSITION TO DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MANNOSE-BINDING LECTIN; NEUTROPENIA; ONCOLOGY SERVICE, HOSPITAL; POLYMORPHISM, GENETIC; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 79958162220     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04398.x     Document Type: Article

References (28)

1. Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 1996; 17:532-40.
2. Brouwer N, Dolman KM, van Zwieten R etal. Mannan-binding lectin (MBL)-mediated opsonization is enhanced by the alternative pathway amplification loop. Mol Immunol 2006; 43:2051-60.
3. Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency - revisited. Mol Immunol 2003; 40:73-84.
4. Neth O, Hann I, Turner MW, Klein NJ. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 2001; 358:614-18.
5. Mullighan CG, Heatley S, Doherty K etal. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 2002; 99:3524-9.
6. Peterslund NA, Koch C, Jensenius JC, Thiel S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 2001; 358:637-8.
7. Bergmann OJ, Christiansen M, Laursen I etal. Low levels of mannose-binding lectin do not affect occurrence of severe infections or duration of fever in acute myeloid leukaemia during remission induction therapy. Eur J Haematol 2003; 70:91-7.
8. Frakking FN, van de Wetering MD, Brouwer N etal. The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia. Eur J Cancer 2006; 42:909-16.
9. Lausen B, Schmiegelow K, Andreassen B etal. Infections during induction therapy of childhood acute lymphoblastic leukemia - no association to mannose-binding lectin deficiency. Eur J Haematol 2006; 76:481-7.
10. Fidler KJ, Wilson P, Davies JC etal. Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin. Intens Care Med 2004; 30:1438-45.
11. Hellemann D, Larsson A, Madsen HO etal. Heterozygosity of mannose-binding lectin (MBL2) genotypes predicts advantage (heterosis) in relation to fatal outcome in intensive care patients. Hum Mol Genet 2007; 16:3071-80.
12. Schmiegelow K, Garred P, Lausen B etal. Increased frequency of mannose-binding lectin insufficiency among children with acute lymphoblastic leukemia. Blood 2002; 100:3757-60.
13. Pine SR, Mechanic LE, Ambs S etal. Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity gene. J Natl Cancer Inst 2007; 99:1401-9.
14. Zehnder A, Fisch U, Hirt A etal. Prognosis in pediatric hematologic malignancies is associated with serum concentration of mannose-binding lectin-associated serine protease-2 (MASP-2). Pediatr Blood Cancer 2009; 53:53-7.
15. Pollack MM, Ruttimann UE, Getson PR. Pediatric risk of mortality (PRISM) score. Crit Care Med 1988; 16:1110-16.
16. Tacx AN, Groeneveld AB, Hart MH etal. Mannan binding lectin in febrile adults: no correlation with microbial infection and complement activation. J Clin Pathol 2003; 56:956-9.
17. Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6:2-8.
18. Ascioglu S, Rex JH, de Pauw B etal. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34:7-14.
19. Wilkinson JD, Pollack MM, Ruttimann UE etal. Outcome of pediatric patients with multiple organ system failure. Crit Care Med 1986; 14:271-4.
20. Thiel S, Holmskov U, Hviid L etal. The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin Exp Immunol 1992; 90:31-5.
21. Carlsson M, Sjoholm AG, Eriksson L etal. Deficiency of the mannan-binding lectin pathway of complement and poor outcome in cystic fibrosis: bacterial colonization may be decisive for a relationship. Clin Exp Immunol 2005; 139:306-13.
22. Nauta AJ, Raaschou-Jensen N, Roos A etal. Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur J Immunol 2003; 33:2853-63.
23. Ogden CA, deCathelineau A, Hoffmann PR etal. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 2001; 194:781-95.
24. Stuart LM, Takahashi K, Shi L etal. Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J Immunol 2005; 174:3220-6.
25. Beachy PA, Karhadkar SS, Berman DM. Mending and malignancy. Nature 2004; 431:402.
26. Schlapbach LJ, Aebi C, Otth M etal. Serum levels of mannose-binding lectin and the risk of fever in neutropenia pediatric cancer patients. Pediatr Blood Cancer 2007; 49:11-16.
27. Schlapbach LJ, Aebi C, Otth M etal. Deficiency of mannose-binding lectin-associated serine protease-2 associated with increased risk of fever and neutropenia in pediatric cancer patients. Pediatr Infect Dis J 2007; 26:989-94.
28. Shi L, Takahashi K, Dundee J etal. Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med 2004; 199:1379-90.